Loading provider…
Loading provider…
Hematology & Oncology Physician in Las Vegas, NV
NPI: 1336156199Primary Practice Location
SUNRISE HOSPITAL AND MEDICAL CENTER
3186 S Maryland Pkwy, Las Vegas, NV
Primary Employer
Comprehensive Cancer Centers of Nevada
cccnevada.com
HQ Phone
Get MD Edwin's Phone Numberphone_androidMobile
Get MD Edwin's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNV State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 36415Insertion of needle into vein for collection of blood sample | 591 | 2,359 |
| 2 | 85025Complete blood cell count (red cells, white blood cell, platelets), automated test | 573 | 2,166 |
| 3 | 80053Blood test, comprehensive group of blood chemicals | 523 | 1,414 |
| 4 | 99214Established patient office or other outpatient visit, 30-39 minutes | 391 | 801 |
| 5 | 99213Established patient office or other outpatient visit, typically 15 minutes | 345 | 601 |
Cancer survivorship in hematologic malignancies: Lifestyle changes after diagnosis.
Authors: Delva Deauna-Limayo, Manas Agastya, Pannaga Malalur, Sandhya Wahi-Gururaj
Journal: Cancer Med
Publication Date: 2021-02-02
Authors: Mitul Gandhi, Ian Flinn, Jamal Misleh, John Burke, Praveen Tumula, Aileen Cohen, Jennifer Cultrera, Arvind Chaudhry, Moshe Levy, Mazyar Shadman, Sudhir Manda, Syed Zafar, Habte Yimer
Journal: Haematologica
Publication Date: 2024-07-01
Authors: Mitul Gandhi, Ian Flinn, Jamal Misleh, John Burke, Praveen Tumula, Aileen Cohen, Arvind Chaudhry, Moshe Levy, Mazyar Shadman, Sudhir Manda, Syed Zafar, Habte Yimer, Subramanya Rao
Journal: Lancet Haematol
Publication Date: 2022-11-16
Lead Sponsor: GlaxoSmithKline
Intervention / Treatment: DRUG: Belantamab mafodotin, DRUG: Pom/dex (Pomalidomide plus low dose Dexamethasone)
Lead Sponsor: BeiGene
Intervention / Treatment: DRUG: Zanubrutinib, DRUG: Obinutuzumab
Lead Sponsor: Seagen Inc.
Intervention / Treatment: DRUG: brentuximab vedotin